SEC Form 4 · accession 0001140361-16-066762
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome M Hauer
Director
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 9:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 19, 2016 | A | 5,985 | $0.00 | A | 20,085 | D | |
| Common StockF1,F3,F4 | May 19, 2016 | S | 3,134 | $41.22 | D | 16,951 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- F2The restricted stock units vest in three equal annual tranches beginning in May 2017.
- F3The restricted stock units vest annually in May 2016 through May 2018.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.20 to $41.30, inclusive.